treatment, cell apoptosis is induced by chemotherapeutic agents, involving excessive production of reactive oxygen species (ROS) and DNA damage. 5 Antioxidants may accelerate the growth of early tumour progression in mice. 6 Third, riboflavin, a coenzyme of some important oxidation reduction enzymes, participates in cell biological oxidation and increases cell anti-oxidation. The insufficiency of riboflavin reduces the antioxidant capability of cells against ROS.
7,8
Moreover, the interference of riboflavin metabolism improves the sensitivity and reduces the adhesion and migration of ovarian cancer cells to Diamminedichloroplatinum (DDP). These effects are associated with the reduced percentage of stem cell-like tumour cells. 9, 10 Therefore, interfering with riboflavin metabolism may be a potential target for CSCs.
Lumiflavin, a natural inhibitor of riboflavin ( Figure 1 ), can prevent the conversion of riboflavin into flavin adenine dinucleotide (FAD) and flavin mononucleotide, and can interfere with the physiological effect of riboflavin. 11, 12 In this study, we explore the efficacy of lumiflavin, a riboflavin inhibitor, in both murine models and human cell lines in vivo and in vitro and found that it synergized with DDP therapy in ovarian cancer. Our results show that the key pathways, such as riboflavin metabolic pathway, are essential in the action maintenance of CSCs and DDP chemoresistance, suggesting an important clinical application of lumiflavin in ovarian cancer therapy. 
| MATERIAL AND ME THODS

| Cell line, drugs, animal, reagents and equipment
| Magnetic bead separation and flow cytometry
HO8910 cells were cultured in DMEM containing 10% foetal bovine serum (FBS) supplemented with 1 × 10 5 IU/L each of penicillin and streptomycin at 37°C in 5% CO 2 atmosphere. The medium was changed every 2-3 days depending on cell growth. Cancer stem-like cells were isolated through magnetic bead sorting by using a magnetic cell sorting system (MACS) based on a previous study.
13,14
Briefly, the cells were harvested from each of the HO8910 cell lines.
According to the manufacturer's instructions, the cells were then labelled with CD133 antibodies conjugated to magnetic beads (Miltenyi Biotec) and then co-labelled with CD133 conjugated to PE (Miltenyi Biotec). Antibody positive and negative cells were then separated using MACS-LS separation columns (Miltenyi Biotec) and identi- was amplified using the following forward and reverse primers as previously described 17, 18 : forward: 5′-CCTTTCC GAA GTGCCCATC-3′ and reverse: 5′-AGAAGGT GGTGAGGTAGTA GG-3′; and β-actin, forward: 5′-AGCCAGACCGTCTCCTTG TA-3′
and reverse: 5′-TAGAGAG GGCC CACCACAC-3′. The human β-actin housekeeping gene was used as an internal control. The primers were designed and synthesized at Shanghai Generay Biotech (Shanghai, China). After carrying out the reaction, the results were analysed using the computational fluid dynamics X Connect RT-PCR System. The relative expression level of the mRNA in each sample was calculated by normalizing its threshold cycle (Ct) value to the Ct value of β-actin housekeeping gene by using the 2 −ΔΔCt method. These levels were expressed in arbitrary units. The RFT2 expression of HO8910 was detected using Western blot analysis.
The total protein from the CSCs and NON-CSCs was prepared under reducing conditions by using 4%-12% Bis-Tris SDS-PAGE gels before being blotted and detected using anti-RFT2 Rabbit antibody (ab223094; Abcam, USA). Protein expression analysis was performed with the Imagej 1.44 Quant software. The distribution of RFT2 in cells was detected using immunofluorescence method.
Cancer stem-like cells and NON-CSCs were washed thrice by using PBS, and the cells were fixed using 4% paraformaldehyde for 30 minutes. The 0.1% Triton X-100 solution was used to cover the cell surface, followed by permeabilization for 30 minutes and blocking with 5% bovine serum protein solution for 2 hours at 37°C. Primary antibody (ab223094; Abcam) was added after rinsing the cells thrice by using PBS, followed by incubation overnight at 4°C. Diluted fluorescent secondary antibody was added after rinsing the cells thrice by using PBS, followed by incubation for 60 minutes at 37°C in the dark. After 4',6-diamidino-2-phenylindole (DAPI)-staining of the nuclei, the expression of RFT2 (red fluorescence) was detected through laser confocal microscopy. Imagej 1.44e professional image analyzer was used to analyse the intensity of the fluorescent expression. 
| Cell vitalities detected by CCK-8 kit [Cell counting kit-8, Sodium 4-(3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-2H-tetrazol-3-ium-5-yl) benzene-1,3-disulfonate (WST-8)]
Cells were collected and the cell viability was determined using Jiangsu, China) accordance to the manufacturer's protocol.
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The cells were incubated at 37°C for 20 minutes, and the centrifugal cells were washed twice with 4°C buffer. The mitochondrial membrane potential (Δψ m ) was determined using the JC-1 probe according to the manufacturer's instruction, and the data were analysed using an Accuri C6 flow cytometer. The stained cells were analysed using a flow cytometer equipped with the CellQuest software.
| ROS level detected by flow cytometry
A total of 2 × 10 5 cells from each group was collected 48 hours after drug treatment through centrifugation. The cells were suspended with serum-free medium, and then incubated at 37°C for 20 minutes. The supernatants were removed after centrifugation, and the cells were washed thrice times by using the serum-free medium.
Finally, the ROS levels were detected using the 2,7-Dichloro-dihydrofluorescein Diacetate (DCFH-DA) kit (Beyotime Institute of Biotechnology), according to the manufacturer's instructions. The ROS levels (10 4 DCF-H) were detected using an Accuri C6 flow cytometer equipped with the CellQuest software. and DDP + riboflavin. All group mice were treated for 25 days. The tumour size was monitored twice a week, while tumour weight was measured at the end of the experiment. 18 Tumour size was measured using the following formula: The tumour tissues of mice were washed with cold saline, weighed and then made into 10% homogenate by adding normal saline.
The homogenate was then centrifuged at 5000 g for 10 minutes
at 40°C to prepare the supernatant. The activities of GSH-PX and SOD and the MDA content were measured directly using the commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). 
| Data analysis
All experiments were repeated at least three times and the data are presented as the mean ± S.D. Differences between data groups were evaluated for significance using the Student's t test of unpaired data (two-tailed). For animal studies, the data are presented as the mean ± S.E.M. The F test for the homogeneity of variance was conducted.
The tumour volume was analysed with one-way ANOVA using the software SPSS 11.5 for Windows (Chicago, IL, USA). Significant and highly significant differences were considered at P < 0.05 and P < 0.01 respectively. 
| RE SULTS
| Effects of lumiflavin combined with mitochondrial membrane potential of DDP, ROS, and apoptotic and colony-forming ability on CSCs
The synergistic effect of lumiflavin and DDP on CSCs was further explored. Mitochondrial membrane potential, ROS contents, and
apoptotic and multiplication capacity were tested through flow cytometry and plate clone formation assay. The results show that lumiflavin could synergistically increase the effect of DDP on CSCs F I G U R E 2 Difference in the cancer stem-cell surface markers, riboflavin content, expression levels of riboflavin transporter 2 (RFT2) gene and protein, sensitivity to DDP, and the synergistic effect of lumiflavin and DDP between cancer stem-like cells (CSCs) and NONCSCs. CSCs of human ovarian cancer cell lines HO8910 were isolated through magnetic bead sorting (CD133+). Co-expression of CD133+/ CD117+, CD44+/CD177, CD44+/CD24− were detected through flow cytometry, riboflavin contents were detected using ultra-high performance liquid chromatography-tandem mass spectrometry, and expression levels of the RFT2 mRNA and protein were examined using RT-PCR, Western blot analysis and immunofluorescence methods. 
| Synergistic effect of lumiflavin and DDP on CSCs, and antagonistic effect of riboflavin on DDP in a xenograft model
To verify the synergistic effect of lumiflavin on ovarian cancer CSCs in vivo, CSCs were inoculated under the skin to replicate the xenograft model. The tumour weight and tumour growth curve show that F I G U R E 3 Synergistic effects of lumiflavin and DDP on mitochondrial membrane potential, reactive oxygen species (ROS) contents, apoptosis rate, and clonality of cancer stem-like cells (CSCs). CSCs were seeded in 6-well plates (1 × 10 6 cells per well). Cells were randomly divided into the control group, lumiflavin (20 μmol/L) group, DDP (20 μmol/L) group, DDP + lumiflavin (20 μmol/L) group and DDP (20 μmol/L) + riboflavin (20 μmol/L) group. After treatment for 48 hours, the membrane potential, ROS contents and apoptosis rate were detected using a flow cytometer. CSCs were seeded in 6-well plates (2 × 10 3 /well) and held for 2 weeks. The colony were fixed and then stained with crystal violet to evaluate the colony formation. A, Flow cytometry scatter plot of the potential of the mitochondrial membrane (Δψ m ) of cells as detected through flow cytometry by using a JC-1 probe. B, Statistical analysis graph of (A). C, Flow cytometry of ROS levels as detected using the DCFH-DA kit. D, Statistical analysis graph of (C). E, Flow cytometry of cell apoptosis as detected using Annexin V-FITC. F, Statistical analysis graph of (E). G, Images of colony formation assay. H, Statistical analysis graph of (G). *P < 0.05 compared to control group; **P < 0.01 compared to control group. # P < 0.05 compared to DDP group; ## P < 0.01 compared to DDP group. Mean ± SD (n = 6) 
| Effects of lumiflavin combined with DDP on apoptosis-related proteins in a xenograft model
To further explore the mechanism of action of lumiflavin and DDP, apoptosis-related proteins, such as cleaved caspase 3, Bax, B-cell lymphoma-2 (BCL-2) and Bas were detected using Western blot analysis.
The results show that the expression of caspase 3 and the apoptotic marker proteins (Bax and Bas) could be increased by DDP (compared to DDP group, P < 0.05 or 0.01), and lumiflavin could exacerbate this phenomenon (compared to DDP group, P < 0.05). Furthermore, riboflavin could decrease the expression of Bax under DDP treatment and increase the expression of BCL-2, a protein that inhibits apoptosis.
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(compared to DDP group, P < 0.05 or 0.01) ( Figure 4A,B) .
| Competitively antagonized content of riboflavin in tumour stem cells in vivo by lumiflavin
To determine the correlation between lumiflavin and riboflavin in vivo, the content of riboflavin in tumour tissues was detected group; **P < 0.01 compared to control group. # P < 0.05 compared to DDP group; ## P < 0.01 compared to DDP group.
Mean ± SD (n = 5)
that lumiflavin competitively inhibited the riboflavin content on the DDP treatment group compared to the DDP group (P < 0.01).
Furthermore, in tumour tissues, the riboflavin content in the groups of lumiflavin combined with DDP is lower than that in the control and DDP group (P < 0.01) as shown in Figure 5A ,B.
| D ISCUSS I ON
The cellular function and characteristics of CSCs are closely related to those of riboflavin. Bela Ozsvari et al reported that diphenyleneiodonium, an inhibitor of riboflavin, can eliminate CSCs in tumours and promote cells in a state of metabolic-quiescence or 'suspended animation'. 33 In this study, we examined the riboflavin content and the gene and protein expression of RFT2, which is the main ribofla- Mitochondrial damage is the key event in cell apoptosis. DDP damages the mitochondria, consuming antioxidant enzymes, such as GSH-PX and SOD, and triggers the irreversible process of apoptosis. 38, 39 It promotes MDA accumulation, which strengthens cell mitochondrial damage. 40 Riboflavin is very important for maintaining mitochondrial function, while lumiflavin can inhibit riboflavin uptake and suppress the conversion of riboflavin to FAD. 41, 42 In the present study, lumiflavin assisted DDP to reduce the potential of the This study was also supported by Hi-bio Science & Technology Co., Ltd. of Hangzhou.
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